Clinical

Dataset Information

0

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of fluorouracil, leucovorin, and gemcitabine in treating patients with recurrent or metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2002594 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
| 2006400 | ecrin-mdr-crc
Clinical Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2002836 | ecrin-mdr-crc
Clinical Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2004017 | ecrin-mdr-crc
Clinical Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2006173 | ecrin-mdr-crc
Clinical Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2002974 | ecrin-mdr-crc
Clinical Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
| 2008706 | ecrin-mdr-crc
Clinical Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
| 2003528 | ecrin-mdr-crc
Clinical Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
| 2003500 | ecrin-mdr-crc
Clinical Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2002816 | ecrin-mdr-crc
Clinical Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
| 2006855 | ecrin-mdr-crc